Back to discover
Drug
Apigenin
Research stageEmerging researchRising momentum
3
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Research2023-09-26Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds.
Research2022-09-06Oxidative medicine and cellular longevity
The Therapeutic Potential of Apigenin.
Research2019-03-15International journal of molecular sciences
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Apigenin
RxNorm CUI
1368130
ChEMBL ID
CHEMBL28
UNII
7V515PI7F6
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Publications over time
20192023
Most influential
Major research themes4
Anti-Infective Agents1Flavones1Glucose1Protein Serine-Threonine Kinases1
Journals, researchers & institutions
Top journals
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)1
- International journal of molecular sciences1
- Oxidative medicine and cellular longevity1
Leading researchers
- Antolak H1
- Azzini E1
- Behrens MD1
- Chagas MDSS1
- Durazzo A1
- Gonçalves-de-Albuquerque CF1
- Jiang J1
- Kręgiel D1
Leading institutions
free-text, unnormalised
- "Sapienza" Università di Roma1
- Bam University of Medical Sciences1
- CEB-Centre of Biological Engineering1
- CREA-Research Centre for Food and Nutrition1
- Faculty of Pharmacy of University of Coimbra Azinhaga de Santa Comba1
- Food Safety Research Center (salt)1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature